Innovative Technology Focus Immuneed's proprietary ID.Flow technology leverages donated human blood to enhance preclinical research accuracy, presenting an opportunity to sell advanced biotech tools or complementary lab technologies that support immune reaction studies.
Recent Leadership Change The appointment of Charlotte Leife as CEO suggests a potential window for targeted outreach to support strategic growth initiatives or new product launches under her leadership.
Recent Asset Sale Immuneed's divestment of immunotherapy assets to Ultimovacs indicates a shift in business focus and opens a dialogue regarding potential partnership or acquisition opportunities in specialized biotech R&D.
Funding and Revenue Scale With modest funding and revenue under one million dollars, Immuneed represents an emerging player with potential appeal for early-stage collaborations or investments in innovative preclinical research solutions.
Market Positioning Operating in the research services industry with a niche focus on immune responses, Immuneed could benefit from sales strategies targeting biotech and pharmaceutical companies expanding their immunotherapy pipelines.
$250M$500M
$1M$10M
$1B$10B
$1M
$10B
$1B$10BImmuneed uses 8 technology products and services including Amazon Web Services, Cybot, Webpack, and more. Explore Immuneed's tech stack below.
| Immuneed Email Formats | Percentage |
| First.Last@immuneed.com | 48% |
| First.Middle@immuneed.com | 2% |
| First.Last@immuneed.com | 48% |
| First.Middle@immuneed.com | 2% |
Research ServicesSweden11-50 Employees
Our technology, ID.Flow, utilizes freshly donated human blood to help researchers better understand drug-induced immune reactions during non-clinical development. By improving the accuracy and relevance of safety and efficacy assessments, we reduce the need for animal studies and enhance the translatability of preclinical findings.
Company Overview
Funding & FinancialsImmuneed has raised a total of $504K of funding over 1 rounds. Their latest funding round was raised on Sep 13, 2016 in the amount of $504K.
Immuneed's revenue is estimated to be in the range of $1M
Funding & FinancialsImmuneed has raised a total of $504K of funding over 1 rounds. Their latest funding round was raised on Sep 13, 2016 in the amount of $504K.
Immuneed's revenue is estimated to be in the range of $1M
1-888-653-2347 
support@leadiq.com